Decision to list medical devices supplied by InterMed Medical Limited
What we’re doing
We're pleased to announce the approval of a listing agreement with InterMed Medical Limited (“InterMed”) for the supply of medical devices in the following category:
- Anaesthetic machines, invasive ventilators, neonatal care and critical care patient monitoring (“Critical Care”)
In summary this will result in:
InterMed’s medical devices in the above category being listed in Part III of Section H of the Pharmaceutical Schedule from 1 March 2024 under a national agreement that all Te Whatu Ora hospitals may purchase under; and
Te Whatu Ora hospitals being able to purchase other suppliers’ brands of medical devices from the above categories as the agreement is not for sole supply.
Any changes to the original proposal?
Some changes to products and pricing were made after the consultation period based on feedback provided which resulted in a delay to the listing date.
Who we think will be most interested
- Te Whatu Ora staff including but not limited to the following areas:
- Clinical engineers and maintenance services
- ICU/ HDU/ NICU
- Patient Monitoring
- Perioperative staff
- Procurement and supply chain
- Wards and Outpatient Clinics
- Suppliers and wholesalers
Detail about this decision
In October 2020, Pharmac issued a Requests for Proposal (“RFP”) for Anaesthetic Machines, Invasive Ventilators, Neonatal Care and Critical Care Patient Monitoring. The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
After completing the evaluation processes, and consulting on the provisional agreement with InterMed, Pharmac has decided to list InterMed's Critical Care devices in Part III of Section H of the Pharmaceutical Schedule from 1 March 2024.
Te Whatu Ora hospitals can continue to choose which Critical Care devices they purchase, including those from other suppliers. Te Whatu Ora hospitals that purchase medical devices in these categories from InterMed must do so under the terms and conditions, including pricing, in the agreement from 1 March 2024.
Our response to what you told us
We’re really grateful for the time people took to respond to this consultation. Feedback was received on some pricing and maintenance terms included in the provisional agreement with InterMed. All feedback was discussed with InterMed and changes to products and pricing were made accordingly.
If you have any questions about this decision, you can email us at email@example.com; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 660 050.